Drug Profile


Alternative Names: Liazal; R 75251; R 85246

Latest Information Update: 19 Jul 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Janssen Pharmaceutica
  • Class Antineoplastics; Antipsoriatics; Imidazoles; Small molecules
  • Mechanism of Action Aromatase inhibitors; Cytochrome P 450 enzyme system inhibitors; Retinoic acid metabolism modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ichthyosis

Highest Development Phases

  • Discontinued Bladder cancer; Breast cancer; Ichthyosis; Prostate cancer; Psoriasis

Most Recent Events

  • 20 Jan 2006 Phase-II/III clinical trials in Ichthyosis in Canada (PO)
  • 20 Jan 2006 Phase-II/III clinical trials in Ichthyosis in Europe (PO)
  • 18 Aug 2005 Clinical development is ongoing for Ichthyosis in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top